EUVIMEDEUVIMED entdecken
Crossref

Short‐Term Effectiveness of a Stepped‐Care Model to Address Fear of Cancer Recurrence in Patients With Early‐Stage Melanoma

Jake R Thompson iD, Lisa Gomes iD, Grace Kouvelis iD, Andrea L Smith iD, Serigne N Lo iD, Nadine A Kasparian iD, Robyn P M Saw iD, Mbathio Dieng iD, Linda Seaman, Linda K Martin iD, Pascale Guitera iD, Donna Milne iD und 3 weitere

Psycho-Oncology · 2024

DOI: 10.1002/pon.70041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psycho-Oncology, 2024. Verfasst von Jake R Thompson und 14 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, University of Sydney, Camperdown, Australia. Hauptthemen laut MEDLINE: Melanoma, Fear, Neoplasm Recurrence, Local, Quality of Life. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Bill and Patricia Ritchie Foundation, Melanoma Institute Australia, University of Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the effectiveness of the Melanoma Care Programme when implemented into routine clinical practice coupled with fear of cancer recurrence (FCR) screening and a stepped‐care model of intervention delivery.

Methods

Using a Type‐I hybrid effectiveness‐implementation design, individuals with stage 0‐II melanoma and a Fear of Cancer Recurrence Inventory FCR severity score of ≥ 13 were offered the Melanoma Care Programme. The programme included a psychoeducational booklet and 3 to 5 psychotherapeutic telehealth sessions with a clinical psychologist, timed around routine dermatological appointments. Multivariable linear mixed modelling was used to analyse the effect of the intervention at 1‐week post‐intervention on patient‐reported outcomes, including FCR severity (primary outcome), symptoms of depression, anxiety, and stress, melanoma‐related knowledge, and health‐related quality of life.

Results

One hundred and twelve participants completed the intervention from 146 participants screened for FCR. Adjusted multivariable linear mixed modelling demonstrated that participants who received the intervention reported a reduced FCR severity at 1‐week post‐intervention (mean change: −3.81 [95% CI: −4.67, −2.95], p < 0.001) compared to baseline. Participants also reported improvements in melanoma‐related knowledge (mean change: 0.64 [95% CI: 0.13, 1.15], p = 0.014), depressive symptoms (mean change: −1.41 [95% CI: −1.92, −0.90], p < 0.001), anxiety (mean change: −1.05 [95% CI: −1.48, −0.61], p < 0.001), stress (mean change: −1.58 [95% CI: −2.22, −0.93], p < 0.001), and health‐related quality of life (mean change: 4.05 [95% CI: 2.84, 5.26], p < 0.001).

Conclusions

The Melanoma Care Programme maintained effectiveness when implemented into routine clinical practice with the addition of FCR screening and a stepped care model of delivery. Trial Registration This study is registered with the Australia and New Zealand Clinical Trials Register (ACTRN12621000145808)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaFearNeoplasm Recurrence, LocalQuality of LifeAnxietySkin NeoplasmsDepressionHumansMaleFemaleMiddle AgedAgedAdultTelemedicineNeoplasm StagingPatient Education as TopicStress, Psychological

Stichwörter der Autor:innen

cancerfear of cancer recurrenceimplementationmelanomaoncologypsychological interventionpsycho‐oncologyscreeningstepped‐care

Autor:innen und Institutionen

  • Faculty of Medicine and Health, University of Sydney, Camperdown, Australia.
  • Melanoma Institute Australia, University of Sydney, Wollstonecraft, Australia.
  • The Daffodil Centre, A Joint Venture with Cancer Council NSW, the University of Sydney, Sydney, Australia.
  • Heart and Mind Wellbeing Center, Heart Institute and the Division of Behavioural Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, Australia.

ORCID-Profile: Jake R Thompson, Lisa Gomes, Grace Kouvelis, Andrea L Smith, Serigne N Lo, Nadine A Kasparian, Robyn P M Saw, Mbathio Dieng, Linda K Martin, Pascale Guitera, Donna Milne, Anne E Cust, Iris Bartula

Förderung

  • Bill and Patricia Ritchie Foundation
  • Melanoma Institute Australia
  • University of Sydney
  • National Health and Medical Research Council
  • Melanoma Centre of Research Excellence
  • National Heart Foundation of Australia Future Leader Fellowship
  • Heart Institute Research Core at Cincinnati Children's Hospital
  • NHMRC Investigator

Zitieren

APA

Thompson, J. R., Gomes, L., Kouvelis, G., Smith, A. L., Lo, S. N., Kasparian, N. A., Saw, R. P. M., Dieng, M., Seaman, L., Martin, L. K., Guitera, P., Milne, D., Schmid, H., Cust, A. E., & Bartula, I. (2024). Short‐Term Effectiveness of a Stepped‐Care Model to Address Fear of Cancer Recurrence in Patients With Early‐Stage Melanoma. Psycho-Oncology. https://doi.org/10.1002/pon.70041

Vancouver

Thompson JR, Gomes L, Kouvelis G, Smith AL, Lo SN, Kasparian NA, et al. Short‐Term Effectiveness of a Stepped‐Care Model to Address Fear of Cancer Recurrence in Patients With Early‐Stage Melanoma. Psycho-Oncology. 2024. doi:10.1002/pon.70041

BibTeX
@article{Thompson2024,
  author = {Thompson, Jake R and Gomes, Lisa and Kouvelis, Grace and Smith, Andrea L and Lo, Serigne N and Kasparian, Nadine A and Saw, Robyn P M and Dieng, Mbathio and Seaman, Linda and Martin, Linda K and Guitera, Pascale and Milne, Donna and Schmid, Helen and Cust, Anne E and Bartula, Iris},
  title = {Short‐Term Effectiveness of a Stepped‐Care Model to Address Fear of Cancer Recurrence in Patients With Early‐Stage Melanoma},
  journal = {Psycho-Oncology},
  year = {2024},
  doi = {10.1002/pon.70041}
}
Kostenlos starten →